{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:51:10Z","timestamp":1780325470333,"version":"3.54.1"},"reference-count":8,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1002\/cpt.3294","type":"journal-article","created":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T19:02:21Z","timestamp":1718564541000},"page":"11-13","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Weaning off Thorough<scp>QT<\/scp>Studies"],"prefix":"10.1002","volume":"116","author":[{"given":"Mai","family":"Mehanna","sequence":"first","affiliation":[{"name":"Division of Applied Regulatory Sciences (DARS), Office of Clinical Pharmacology (OCP)\/Office of Translational Sciences (OTS)\/Center for Drug Evaluation and Research (CDER) U.S. FDA Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet H.","family":"van der Graaf","sequence":"additional","affiliation":[{"name":"Certara, Applied BioSimulation Canterbury UK"},{"name":"Leiden Academic Centre for Drug Research Leiden The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,6,16]]},"reference":[{"key":"e_1_2_4_1_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2136"},{"key":"e_1_2_4_2_1","unstructured":"ICH E14\/S7B draft guideline: clinical and nonclinical evaluation of QT\/QTc interval prolongation and proarrhythmic potential question and answers<https:\/\/database.ich.org\/sites\/default\/files\/ICH_E14\u2010S7B_QAs_Step2_2020_0827_0.pdf> (2020) Accessed April 17 2024."},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2029"},{"key":"e_1_2_4_4_1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/cpt.3284","article-title":"Should you run a dedicated TQT study? Sponsor and regulatory considerations on substitution pathways to assess QT liability","volume":"116","author":"Lester R.M.","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_4_5_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cpt.3283","article-title":"Results from a joined prospective study to evaluate the sensitivity of the in\u00a0vivo dog QT assay in line with the ICH E14\/S7B Q&a best practices","volume":"116","author":"Betat A.M.","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_4_6_1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/cpt.3219","article-title":"The efficacy, effectiveness, and efficiency of integrated QTc assessment: rationalizing approaches to new drug modalities","volume":"116","author":"Abernathy M.M.","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_4_7_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/cpt.3204","article-title":"Scientific review of the proarrhythmic risks of oligonucleotide therapeutics: are dedicated ICH S7B\/E14 studies needed for low\u2010risk modalities?","volume":"116","author":"Qu Y.","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3047"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.3294","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T23:29:37Z","timestamp":1732231777000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.3294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,16]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1002\/cpt.3294"],"URL":"https:\/\/doi.org\/10.1002\/cpt.3294","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,16]]},"assertion":[{"value":"2024-04-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}